Aktie A237690 ST PHARM CO.,LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen ST Pharm Co.,Ltd.

Aktien

A237690

KR7237690003

A237690

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 16.05.2024 		% 5 Tage % 1. Jan.
96 100 KRW +0,10 % Intraday Chart für ST Pharm Co.,Ltd. +3,78 % +41,74 %
2023 ST Pharm Co.,Ltd. meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
ST Pharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
ST Pharm Co.,Ltd. Announces Expansion of Oligonucleotide Facility
Samsung Biologics : S.Korea pledges nearly $2 bln to become major COVID-19 vaccine producer
Market Chatter: ST Pharm to Launch mRNA-based COVID-19 Vaccine in 2022
ST Pharm Co.,Ltd. announced that it has received KRW 110 billion in funding
ST Pharm Co.,Ltd. announced that it expects to receive KRW 110 billion in funding
Avidity Biosciences, Inc. announced that it has received $78.999943 million in funding from Alethea Capital Management, LLC, Alexandria Venture Investments, LLC, Takeda Ventures, Inc., CureDuchenne Ventures LLC, ST Pharm Co.,Ltd.
ST Pharm Co.,Ltd. acquired 70% stake in AnaPath GmbH.
Avidity Biosciences, Inc. announced that it expects to receive $76.699946 million in funding from Alethea Capital Management, LLC, Alexandria Venture Investments, LLC, Takeda Ventures, Inc., CureDuchenne Ventures LLC, ST Pharm Co.,Ltd.
Dong-A Socio Holdings Co. Ltd. cancelled the acquisition of an additional stake in ST Pharm Co. Ltd..
Dong-A Socio Holdings Co. Ltd. cancelled the acquisition of additional 10% stake in ST Pharm Co. Ltd. from Dong-A ST Co., Ltd..
ST Pharm Co.,Ltd. cancelled the acquisition of Banwol Factory from Dong-A ST Co., Ltd..
ST Pharm Co. Ltd.(KOSDAQ:A237690) added to S&P Global BMI Index
Dong-A Socio Holdings Co. Ltd. made a tender offer to acquire an additional stake in ST Pharm Co. Ltd. for approximately KRW 170 million.
ST Pharm Co. Ltd. has completed an IPO in the amount of KRW 135.26 billion.
ST Pharm Co. Ltd. has filed an IPO.
Dong-A Socio Holdings Co. Ltd. agreed to acquire additional 10% stake in ST Pharm Co. Ltd. from Dong-A ST Co., Ltd. for KRW 25.9 billion.
ST Pharm Co.,Ltd. agreed to acquire Banwol Factory from Dong-A ST Co., Ltd. for KRW 51 billion.
Dong-A Socio Holdings Co. Ltd. completed the acquisition of additional 2.7% stake in Dong-A ST Co.,Ltd from Jung-Seok Kang, ST Pharm Co. Ltd., Sangju Academy and others.
Dong-A Socio Holdings Co. Ltd. made an offer to acquire additional 2.7% stake in Dong-A ST Co.,Ltd from Jung-Seok Kang, ST Pharm Co. Ltd., Sangju Academy and others for KRW 19.9 billion.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A237690 Aktie
  4. Nachrichten ST Pharm Co.,Ltd.
  5. Andere Sprachen